angiotensin ii has been researched along with Lymphopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
André, S; Boulle, C; Cezar, R; Claret, PG; Corbeau, P; Duvnjak, S; Estaquier, J; Gimenez, S; Kundura, L; Lefrant, JY; Lin, YL; Loubet, P; Lozano, C; Mettling, C; Muller, L; Pasero, P; Portalès, P; Reynes, J; Roger, C; Sotto, A; Tran, TA; Vincent, T; Younas, M | 1 |
1 other study(ies) available for angiotensin ii and Lymphopenia
Article | Year |
---|---|
Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19.
Topics: Angiotensin II; Apoptosis; COVID-19; DNA Damage; Humans; Lymphopenia; Reactive Oxygen Species; SARS-CoV-2; T-Lymphocytes | 2022 |